Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

New & experimental HIV treatments

Once-daily extended-release nevirapine works as well as twice-daily formulation

News
23 July 2010
New & experimental HIV treatments

Experimental integrase inhibitor GSK-572 shows continued promise

News
23 July 2010
HIV treatment

Rilpivirine (TMC278) matches efavirenz in phase 3 studies, with fewer side-effects

News
22 July 2010
Drug interactions & pharmacokinetics

IAC: Smoking Has No Impact on Atazanavir Levels

Editor's pick
MedPage Today
22 July 2010
Changing treatment

Protease inhibitor to raltegravir switch maintains viral suppression, but NRTI resistance lowers efficacy

News
22 July 2010
Pregnancy, children & young people

Low birth weight seen in small minority of infants exposed to some antiretroviral drugs

News
22 July 2010
HIV treatment

IAC: Nano-Sized Efavirenz Looks Doable

Editor's pick
MedPage Today
21 July 2010
Health problems in children & young people

Children with HIV are at risk for metabolic problems and heart muscle dysfunction

News
21 July 2010
New & experimental HIV treatments

TBR-652 blocks both CCR5 and CCR2, inhibiting HIV replication and reducing inflammation

News
20 July 2010
Epidemiology

Universal access to HIV treatment threatened by failure of will

News
20 July 2010
Support issues for children & young people

Adolescents living with HIV face complex psychosocial concerns: require targeted, comprehensive services

News
20 July 2010
Side effects

IAC: Docs Talk But Fail to Communicate HIV Knowledge (CME/CE, with video)

Editor's pick
MedPage Today
20 July 2010
Starting treatment

Lopinavir/ritonavir plus raltegravir NRTI-sparing regimen as effective as traditional HAART

News
20 July 2010
Pregnancy, children & young people

Child mortality falls after mothers receive HIV drugs

News
20 July 2010
Treatment outcomes & life expectancy

Large-scale impact of ART on mortality in Brazil, South Africa: big successes but mind the gaps

News
20 July 2010
Epidemiology

Newer HIV drugs cost-effective for Africa

News
20 July 2010
Treatment guidelines

5.2 million now on ART — and more to come; WHO officially releases 2010 HIV treatment guidelines

News
20 July 2010
HIV treatment

New Initiatives From ADAP Crisis Task Force and Merck

Editor's pick
Poz magazine news
20 July 2010
Treatment guidelines

New HIV treatment guidelines indicate importance of early, individualized antiretroviral treatment

Editor's pick
Science Daily
18 July 2010
Testing & health monitoring

South Africa: Motlanthe to Attend Intl Aids Conference

Editor's pick
AllAfrica
15 July 2010
Neurological & cognitive problems

Maraviroc potentially useful if neurological disease is present

News
15 July 2010
New & experimental HIV treatments

Merck stops development of CCR5 inhibitor vicriviroc

News
15 July 2010
Treatment guidelines

Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti

Editor's pick
New England Journal of Medicine
14 July 2010
New & experimental HIV treatments

Avexa licenses integrase inhibitor to Chinese partner

Editor's pick
Avexa
14 July 2010